← Leaderboards
Lishomwa C Ndhlovu
University Of California, San Francisco
$30,426,942
Attributed
$77,081,977
Total exposure
20
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.2M · FY2010–25$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$77,081,977 · 20
By mechanism
R01$34,500,232 · 11
UM1$27,293,591 · 1
U01$11,123,671 · 2
R37$1,657,972 · 1
U54$1,050,702 · 1
R21$978,463 · 2
Top collaborators
- Susana T Valente10 shared
- Victor Valcour9 shared
- Shelby L Oconnor8 shared
- Charles A. Scanga8 shared
- Teresa A Milner7 shared
- Satish Kumar Pillai7 shared
- Hagen Ulrich Tilgner7 shared
- Mohamed Abdel Mohsen6 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Ana-Claire Lew Meyer$911,161
- Joanna Hellmuth$795,528
- Yvonne Ou$8,730,942
- Felicia C. Chow$4,973,965
- Jeffrey R Johnson$6,636,177
Others in their field
Top investigators on “Antiretroviral Therapy”
- James Dennis Neaton · Northwestern University$279,044,427
- Lawrence Corey · Fred Hutchinson Cancer Center$278,220,635
- Constance Ann Benson · University Of California, San Diego$241,336,455
- Carol Nesel · Westat$188,148,170
- Judith S. Currier · University Of California Los Angeles$182,467,520
- Barbara Driver · Westat, Inc.$170,789,549
Research focus
Antiretroviral TherapyCellsHiv InfectionsImmunePersonsInfectionBrainViralBloodCell TypeChronicVirusInflammationInnovationMicrogliaPhenotypeTissuesNonhuman PrimatePlasmaMediatingSiteGenesCd4 Positive T LymphocytesMolecular
Grant awards (74)
HOPE - HIV Obstruction by Programmed Epigenetics$4,951,244
UM1 · FY2025 · AI
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure$2,276,913
U01 · FY2025 · DA · contact PI
Characterization of Allogeneic T Cells Mediating HIV Cure$1,657,972
R37 · FY2025 · AI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$974,060
R01 · FY2025 · MH
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV$893,519
R01 · FY2025 · MH
Modulation of Galectin-9 to Target HIV Persistence$827,545
R01 · FY2025 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection$784,938
R01 · FY2025 · AI
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$768,201
U01 · FY2025 · DA
Single cell dark matter in the context of HIV and substance use$616,372
R01 · FY2025 · DA
HOPE - HIV Obstruction by Programmed Epigenetics$5,336,026
UM1 · FY2024 · AI
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure$2,276,913
U01 · FY2024 · DA · contact PI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$975,768
R01 · FY2024 · MH
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV$893,519
R01 · FY2024 · MH
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection$793,149
R01 · FY2024 · AI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$783,639
R01 · FY2024 · AG · contact PI
Modulation of Galectin-9 to Target HIV Persistence$775,391
R01 · FY2024 · AI
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$770,902
U01 · FY2024 · DA
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$99,012
R01 · FY2024 · AG · contact PI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$63,017
R01 · FY2024 · AG · contact PI
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment$1
R01 · FY2024 · DA
HOPE - HIV Obstruction by Programmed Epigenetics$6,334,269
UM1 · FY2023 · AI
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure$2,531,125
U01 · FY2023 · DA · contact PI
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents$1,200,666
R01 · FY2023 · AI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$974,407
R01 · FY2023 · MH
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV$893,519
R01 · FY2023 · MH
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$843,815
R01 · FY2023 · NS
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection$826,203
R01 · FY2023 · AI
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$795,857
R01 · FY2023 · AG · contact PI
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$745,247
U01 · FY2023 · DA
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment$737,501
R01 · FY2023 · DA
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$167,632
U01 · FY2023 · DA
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$126,033
R01 · FY2023 · AG · contact PI
HOPE - HIV Obstruction by Programmed Epigenetics$5,336,026
UM1 · FY2022 · AI
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents$1,216,647
R01 · FY2022 · AI
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence$1,165,864
R01 · FY2022 · MH
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV$929,754
R01 · FY2022 · MH
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$847,023
R01 · FY2022 · NS
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$807,613
R01 · FY2022 · AG · contact PI
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment$736,183
R01 · FY2022 · DA
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$715,630
U01 · FY2022 · DA
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$167,632
U01 · FY2022 · DA
Harnessing single cell epigenome-wide profiling of myeloid cells to compare and contrast Alzheimer's from HIV-associated cognitive dysfunction$63,017
R01 · FY2022 · AG · contact PI
HOPE - HIV Obstruction by Programmed Epigenetics$5,336,026
UM1 · FY2021 · AI
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents$1,213,831
R01 · FY2021 · AI
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$843,928
R01 · FY2021 · NS
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$819,055
R01 · FY2021 · AG · contact PI
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment$734,866
R01 · FY2021 · DA
Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV$703,476
U01 · FY2021 · DA
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents$1,218,191
R01 · FY2020 · AI
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression$907,453
R01 · FY2020 · NS
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction$863,930
R01 · FY2020 · AG · contact PI
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment$750,923
R01 · FY2020 · DA
Effects of Human Galectin-9 on the CNS HIV Reservoir$390,408
R01 · FY2020 · MH
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents$1,301,851
R01 · FY2019 · AI
Effects of Human Galectin-9 on the CNS HIV Reservoir$390,387
R01 · FY2019 · MH
Monocytes and Macrophages in HIV Cardiovascular Risk$357,702
U54 · FY2019 · MD · contact PI
Monocytes and HIV CNS Reservoirs in Super Acute HIV Infection$594,366
R01 · FY2018 · MH · contact PI
Effects of Human Galectin-9 on the CNS HIV Reservoir$390,406
R01 · FY2018 · MH
Monocytes and Macrophages in HIV Cardiovascular Risk$346,500
U54 · FY2018 · MD · contact PI
Exploring Cell-free Glycomic Interactions in HIV-associated Neurological Disorders$211,425
R21 · FY2018 · NS
Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities$99,954
K12 · FY2018 · HL
Monocytes and HIV CNS Reservoirs in Super Acute HIV Infection$704,623
R01 · FY2017 · MH · contact PI
Effects of Human Galectin-9 on the CNS HIV Reservoir$390,445
R01 · FY2017 · MH
Monocytes and Macrophages in HIV Cardiovascular Risk$346,500
U54 · FY2017 · MD · contact PI
Exploring Cell-free Glycomic Interactions in HIV-associated Neurological Disorders$295,850
R21 · FY2017 · NS
Reversal of Adaptive Immune Dysfunction in Shock and Kill HIV Cure Strategies$226,543
R21 · FY2017 · AI · contact PI
Monocytes and HIV CNS Reservoirs in Super Acute HIV Infection$602,068
R01 · FY2016 · MH · contact PI
Effects of Human Galectin-9 on the CNS HIV Reservoir$404,966
R01 · FY2016 · MH
Reversal of Adaptive Immune Dysfunction in Shock and Kill HIV Cure Strategies$244,645
R21 · FY2016 · AI · contact PI
Monocytes and HIV CNS Reservoirs in Super Acute HIV Infection$110,726
R01 · FY2016 · MH · contact PI
Monocytes and HIV CNS Reservoirs in Super Acute HIV Infection$597,375
R01 · FY2015 · MH · contact PI
Monocytes and HIV CNS Reservoirs in Super Acute HIV Infection$626,402
R01 · FY2014 · MH · contact PI
Modulating Tim-3 to control HIV infection$240,216
R56 · FY2010 · AI · contact PI
Modulating Tim-3 to control HIV infection$137,176
R56 · FY2010 · AI · contact PI